Case Report: Co-Occurrence of Lung Adenocarcinoma and Congenital Dysfibrinogenemia-Diagnostic and Perioperative Management Challenges.

Key Points

• To address the complexities in diagnosing and managing lung adenocarcinoma alongside congenital dysfibrinogenemia.
• Comprehensive coagulation profiling conducted for patients undergoing pulmonary resection.
• Compared fibrinogen concentrate to plasma-derived products for hemostatic effectiveness.
• Implemented individualized thromboprophylaxis based on genetic risk assessment.
• Identified the necessity of coagulation profiling in candidates for lung surgery.
• Demonstrated that fibrinogen concentrate offers faster and more effective hemostasis in dysfibrinogenemia cases.
• Outlined a targeted approach to managing bleeding and clotting risks during perioperative care.

Abstract